40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer
40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does 40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer have?
40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer has 0 citations in the OpenAlex counts PICO Portal stores.
When was 40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer published?
40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer has 2020 year in the PICO Portal index.
What is the open-access status of 40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer?
40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer has closed oa status in the PICO Portal index.
What is the DOI of 40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer?
The DOI for 40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer is on the source record.
What is the OpenAlex record for 40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer?
The OpenAlex for 40P Efficacy and safety of immune checkpoint inhibitors in previously treated metastatic non-small cell lung cancer is on the source record.